土耳其出生体重>1500g或胎龄>32周早产儿ROP频率、危险因素与结局及医疗法律担忧
土耳其新生儿学会在80个NICU开展前瞻性队列研究(TR-ROP 2),纳入4140例出生体重>1500g或胎龄>32周且临床不稳定或评估有ROP风险的早产儿,任何分期ROP发生率为5.8%,需治疗的重度ROP为0.4%。较低出生体重和胎龄、小于胎龄、红细胞输注、氧疗>5天、机械通气>1天、早发新生儿败血症合并症或≥3种合并症为独立相关因素。出生体重≥2000g者中31.4%因医疗法律原因接受筛查,2.2%发生ROP但无重度ROP。
要点
- 成熟早产儿ROP罕见但可发生,多危险因素并存时仍需警惕。
- 医疗法律担忧可能导致过度筛查,出生体重≥2000g者中31.4%因此被筛查。
- 需制定基于证据的风险适配筛查指南,避免不必要干预。
核心结论
- 在出生体重>1500g或胎龄>32周的早产儿中ROP罕见但可发生,多重危险因素并存时仍可出现需治疗的重度ROP。
- 医疗法律担忧可能促成过度筛查,应制定基于证据的风险适配筛查指南。
研究设计与样本
- 纳入出生体重>1500g或胎龄>32周、临床过程不稳定或被评估有ROP风险的早产儿,共4140例。
主要发现
- 4140例有ROP风险的早产儿中,242例(5.8%)发生任何分期ROP,17例(0.4%)发生需治疗的重度ROP。
- 与ROP独立相关的危险因素包括较低胎龄和出生体重、小于胎龄、红细胞输注、氧疗>5天、机械通气>1天、早发新生儿败血症合并合并症或存在≥3种合并症(不包括早发新生儿败血症)。
- 出生体重≥2000g者中31.4%因医疗法律原因接受筛查,2.2%发生ROP,但无一例重度ROP。
关键数值与推荐
- 任何分期ROP发生率5.8%(242/4140),需治疗的重度ROP发生率0.4%(17/4140)。
- 出生体重≥2000g者中因医疗法律原因筛查者占31.4%,该亚组ROP发生率2.2%,重度ROP为0。
临床怎么用
- 对出生体重>1500g或胎龄>32周但存在多重危险因素(如低胎龄/低出生体重、小于胎龄、红细胞输注、氧疗>5天、机械通气>1天、早发新生儿败血症合并症或≥3种合并症)的早产儿应保持ROP筛查警惕。
- 避免仅因医疗法律担忧而对低风险成熟早产儿进行过度筛查,推动风险适配的筛查策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate the prevalence and risk factors of retinopathy of prematurity (ROP) in preterm infants with a birth weight (BW)>1500 g or gestational age (GA) >32 weeks in Turkiye. METHODS: A prospective cohort study (TR-ROP 2) was conducted in 80 neonatal intensive care units between 30 September 2023 and 1 November 2024. Infants with a BW >1500 g or GA >32 weeks who had an unstable clinical course or were deemed at risk for ROP were included. The effect of medicolegal concerns on the decision to screen was also evaluated. RESULTS: The study included 4140 infants at risk for ROP development; 242 (5.8%) developed any stage of ROP, and 17 (0.4%) developed severe ROP requiring treatment. Risk factors independently associated with ROP included lower GA and BW, being small for GA, red blood cell transfusion, oxygen therapy >5 days, mechanical ventilation >1 day, early neonatal sepsis (ENS) with comorbidities or presence of ≥3 comorbidities (excluding ENS). Of those with BW ≥2000 g, 31.4% were screened for medicolegal reasons; 2.2% developed ROP, but none had severe ROP. CONCLUSIONS: ROP in mature infants is rare but can occur in the presence of multiple risk factors. Medicolegal concerns may contribute to overscreening. Developing evidence-based, risk-adapted screening guidelines is essential to ensure appropriate care without unnecessary interventions.
引用
- Bas AY, Koc E, Unal S, et al. Evaluation of the frequency, risk factors and outcomes of ROP in preterm infants with a BW >1500 g or GA >32 weeks in Turkiye (TR-ROP 2) and medicolegal fears: a Turkish Neonatal Society multicentre study. Br J Ophthalmol. 2026. PMID: 41513433. doi:10.1136/bjo-2025-327674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。